The 2010-2015 Outlook for Hematology and Oncology Products in North America & the Caribbean
The 2010-2015 Outlook for Hematology and Oncology Products in North America & the Caribbean
Book Details
Printable: Yes. This title is printable
Mac OS Compatible: OS 9.x or later
Windows Compatible: Yes
Handheld Compatible: Yes. Adobe Reader is available for PalmOS, Pocket PC, and Symbian OS.
Digital: 37 pages
Publisher: Icon Group International (May 29, 2009).
Book Description
This econometric study covers the outlook for hematology and oncology products in North America & the Caribbean. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.
This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries in North America & the Caribbean). This study gives, however, my estimates for the latent demand, or the P.I.E. for hematology and oncology products in North America & the Caribbean. It also shows how the P.I.E. is divided across the national markets of North America & the Caribbean. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.
